Core Insights - Cardinal Health, Inc. is a healthcare services and products company with a market cap of $36.6 billion, providing a range of services including pharmaceutical distribution and healthcare product manufacturing [1] - The company is expected to announce its fiscal first-quarter earnings for 2026 on October 30, with analysts predicting a profit of $2.21 per share, a 17.6% increase from the previous year [2] - For the full fiscal year, analysts forecast an EPS of $9.45, reflecting a 14.7% increase from $8.24 in fiscal 2025, and an expected rise to $10.58 in fiscal 2027 [3] Stock Performance - Cardinal Health's stock has underperformed compared to the S&P 500 Index, which gained 14.7% over the past 52 weeks, while CAH shares increased by 39% [4] - Following a mixed Q4 earnings report, CAH shares dropped 7.2%, despite an adjusted EPS of $2.08 beating estimates, while revenue of $60.2 billion slightly missed expectations [5] Analyst Ratings - The consensus opinion on CAH stock is bullish, with a "Strong Buy" rating from 11 out of 15 analysts, while four analysts recommend a "Hold" [6] - The average analyst price target for CAH is $179.80, indicating a potential upside of 15.5% from current levels [6]